Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.

@article{Karjalainen2008SafetyOP,
  title={Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.},
  author={Pasi P Karjalainen and Saila Vikman and Matti Niemel{\"a} and Pekka Porela and Antti S Ylitalo and M. Vaittinen and Marja Puurunen and Tuukka J Airaksinen and Kai Nyman and Tero Vahlberg and Kari Eino Juhani Airaksinen},
  journal={European heart journal},
  year={2008},
  volume={29 8},
  pages={
          1001-10
        }
}
AIMS Uninterrupted anticoagulation (UAC) is assumed to increase bleeding and access-site complications. A common consensus is to postpone percutaneous coronary interventions (PCI) to reach international normalized ratio (INR) levels < 1.5-1.8. METHODS AND RESULTS To assess the safety and feasibility of UAC, we analysed retrospectively all consecutive patients (n = 523) on warfarin therapy referred for PCI in four centres with a policy to interrupt anticoagulation (IAC) before PCI and in three… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 56 CITATIONS, ESTIMATED 35% COVERAGE

Performing diagnostic radial access coronary angiography on uninterrupted direct oral anticoagulant therapy: a prospective analysis

Napohn Chongprasertpon, Aiste Zebrauskaite, +4 authors Thomas J. Kiernan
  • Open heart
  • 2019
VIEW 2 EXCERPTS
CITES BACKGROUND

Triple Therapy: When, if Ever?

  • Current Treatment Options in Cardiovascular Medicine
  • 2018

FILTER CITATIONS BY YEAR

2007
2019

CITATION STATISTICS

  • 5 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

A feasibility study of continuing dose - reduced warfarin for invasive procedures in patients with high thromboembolic risk

Larson BJG, MS Zumberg, CS Kitchens
  • Am Heart J
  • 2006